LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway (vol 22, pg 4861, 2018)

被引:0
|
作者
Zhang, Y. [1 ]
Mi, L. [1 ]
Xuan, Y. [1 ]
Gao, C. [1 ]
Wang, Y. -H. [1 ]
Ming, H. -X. [1 ]
Liu, J. [1 ]
机构
[1] Shandong Univ, Prov Hosp, Dept Hepatobiliary Surg, Jinan, Peoples R China
关键词
D O I
10.26355/eurrev_202109_26774
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PATIENTS AND METHODS: LncRNA HOTAIRM1 expressions in 30 pairs of hepatocellular carcinoma tissues and paracancerous tissues were detected by quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT- PCR). The survival analysis and receiver operating characteristic (ROC) curve were introduced to explore the relationship between lncRNA HOTATRM expressions and prognosis of HCC patients. The correlation between overall survival and clinical variables of HCC patients was estimated by single-factor and multiple-factor regression analysis, respectively.
引用
收藏
页码:5578 / 5578
页数:1
相关论文
共 50 条
  • [1] LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway
    Zhang, Y.
    Mi, L.
    Xuan, Y.
    Gao, C.
    Wang, Y-H
    Ming, H-X
    Liu, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (15) : 4861 - 4868
  • [2] HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway
    Hamilton, Michael J.
    Young, Matthew
    Jang, Kay
    Sauer, Silvia
    Neang, Vanessa E.
    King, Alexia T.
    Girke, Thomas
    Martinez, Ernest
    CANCER LETTERS, 2020, 472 : 50 - 58
  • [3] RETRACTION: LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway (Retraction of Vol 13, Pg 8907, 2020)
    Song, X.
    Xu, X.
    Ren, X.
    Ruan, X.
    Wang, Y.
    Yao, T. T.
    ONCOTARGETS AND THERAPY, 2023, 16 : 281 - 281
  • [4] RETRACTION: MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling (vol 106, pg 483, 2018) (Retraction of Vol 106, Pg 483, 2018)
    Cao, Ningjia
    Mu, Liang
    Yang, Wei
    Liu, Li
    Liang, Liang
    Zhang, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [5] TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/-catenin signaling pathway
    Xu, Mingxing
    Hu, Jingxiong
    Zhou, Boxuan
    Zhong, Yuesi
    Lin, Nan
    Xu, Ruiyun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (01) : 68 - 77
  • [6] Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
    Chen, Wei
    You, Jia
    Zheng, Qi
    Zhu, Yue-Yong
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1817 - 1826
  • [7] ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway
    Fan, Sirui
    Zhao, Hongqing
    Li, Cheng
    Chen, Xing
    Sun, Mingjie
    Chen, Fengyang
    Long, Chao
    Zhou, Yinghui
    Nan, Boyuan
    Zhao, Hao
    Zhang, Wei
    BIOCHEMICAL GENETICS, 2024,
  • [8] Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma
    Danyan Gu
    Meng Tong
    Jing Wang
    Bocheng Zhang
    Jinghua Liu
    Guoqiang Song
    Biao Zhu
    Discover Oncology, 14
  • [9] Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
    Zou, Wei-Jie
    Huang, Zhi
    Jiang, Tian-Peng
    Shen, Ya-Ping
    Zhao, An-Su
    Zhou, Shi
    Zhang, Shuai
    MEDICAL SCIENCE MONITOR, 2017, 23 : 6107 - 6113
  • [10] Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma
    Gu, Danyan
    Tong, Meng
    Wang, Jing
    Zhang, Bocheng
    Liu, Jinghua
    Song, Guoqiang
    Zhu, Biao
    DISCOVER ONCOLOGY, 2023, 14 (01)